CIChukwuemeka Kenneth Iregbu

Chukwuemeka Kenneth Iregbu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chukwuemeka Kenneth Iregbu has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The CLIMIDSON Manual for Antimicrobial Stewardship Programmes in Nigerian Health Care Facilities

    by K.C. Iregbu, O.O. Oduyebo, S.S. Taiwo, P.I. Nwajiobi-Princewill, P.O. Oshun, I.N. Nwafia, C.J. Elikwu, M.M. Manga, I.L. Oboro, I.O. Kudayah

    Antimicrobial stewardship (AMS) remains a cornerstone of efforts aimed at improving antimicrobial-related patient safety. It slows the development and spread of antimicrobial resistance (AMR), while helping clinicians to improve clinical outcomes and minimise harm by improving antimicrobial prescribing. AMS programmes (ASPs) are driven through various processes and people. An AMS structure comprises the core elements that should be in place to support the ASP including the AMS team, treatment guidelines, and surveillance of AMR and antimicrobial use (AMU). This manual aims to provide a practical guide to health care facilities in Nigeria and other low-and- middle-income countries, for establishing, implementing and sustaining ASPs, and is structured into 14 sections. Section 1 introduces the subject matter and gives background information on the current situation of AMS in Nigeria. It describes the efforts of the National Antimicrobial Stewardship Working Group (NASWOG), an arm of the Clinical Microbiology and Infectious Diseases Society of Nigeria (CLIMIDSON), in identifying the AMR issues in health care facilities in the country and providing evidence-based recommendations for ASPs. Section 2 describes the goals of AMS and core elements which must be in place for successful and sustainable ASPs. Section 3 presents how a health care facility could start an ASP depending on the size, highlighting the important role of point prevalence survey (PPS) in obtaining baseline data on AMU and prescribing practice in health care facilities, which is useful in developing an action plan. Although management support is key for a successful ASP, the governance of the programme rests with the AMS committee, which composition and size will depend on the level of health care facility. Section 4 describes AMS strategies, which include the core and supplemental strategies. Every hospital should aspire to do at least a core strategy, although it may be convenient to start with other stewardship activities and supplemental strategies. Section 5 describes the antibiotic policy and guidelines, which provide the framework for all AMS activities, and is an effective means of changing behaviour in antimicrobial prescribing. The guidelines should be written by a multidisciplinary team and due consideration must be given to the local antibiotic susceptibility data and the common infectious disease syndromes in the facility or region. Dissemination of the policy and guidelines should be given wide publicity. At the primary health care facilities, where there may be no doctors to prescribe, “standing orders” are used to guide antibiotic prescribing. Section 6 describes the critical importance of stakeholder engagement to a successful ASP. If stakeholders are more informed about AMR issues and ASP, they are better able to positively support the programme. AMS stakeholders will differ from facility to facility but generally include health care facility management, clinicians, pharmacists, nurses, infection prevention and control (IPC) practitioners, clinical microbiologists, other relevant laboratory staff, and patients. The importance of education and training to the successful implementation of AMS is presented in section 7. Health care facilities should provide induction and in-service training to all staff on AMS and IPC. Training objectives should be clear and targets of education and training should include AMS committee and team(s), clinicians, pharmacists, nurses and other health care staff, patients and caregivers, and advocacy and community campaigns. Sections 8 and 9 explain how monitoring and evaluation (M&E) of ASP, and feedback to stakeholders are conducted. Monitoring and evaluation are critical to identifying the impact of intervention measures and opportunities for improvement. This involves the evaluation of the structures, processes and outcomes of ASPs. Sections 10 and 11 delved into the roles of clinical microbiology laboratory support for AMS, and diagnostic stewardship as well as information and communication technology (ICT) in ASPs. The clinical microbiology laboratory should provide quality antibiotic susceptibility testing data, and standard antibiograms periodically to the AMS committee. Sections 12, 13 and 14 enumerated the core elements of outpatient ASP, institutional mentoring in AMS, and system building approach to sustainability of ASP. The recommendations for outpatient AMS in this document apply to either stand-alone clinics and casualties or those located in secondary or tertiary hospitals.


  • Retrospective Characterization of Noma Cases Found Incidentally across Nigeria during Outreach Programs for Cleft Lip from 2011–2020

    by Ngutor Ver-Or, Chukwuemeka Kenneth Iregbu, Olaniyi Olufemi Taiwo, Ikhelua Thomas Afeleokhai, Chiangi Gabriel Aza, Jeremiah Z. Adaji, Charlse Margima

    : Reports of cases of noma in Nigeria remain scarce despite its known and devastating effects on victims. This report presents a retrospective cross-sectional study based on data regarding on patients with noma encountered incidentally during Oral Health Advocacy Initiative outreach on orofacial diseases across 34 states and the Federal Capital Territory in Nigeria over 10 years (2011–2020), which was aimed at contributing to an understanding of the epidemiology of noma in Nigeria. The data were collated and analyzed, and are presented in frequency distribution tables and charts. A total of 7,195 patients with noma were encountered. The northeastern region had the greatest number of patients (n = 1,785, 24.8%) whereas the southwestern region had the least (n = 196, 2.7%). When aggregated by state, Ondo State had the least number of patients (n = 31, 0.4%) whereas Kano State had the greatest (n = 623, 8.7%). Patient age ranged from 3 to 70 years, with a slight male preponderance (56.9%). This report highlights the fact that noma is prevalent in Nigeria but remains neglected, with extensive but preventable physical, emotional, and social debilitation and devastation of the victims across all age groups. There is a need for a more robust survey to determine the true burden of the disease. There is also an urgent need for collaboration between governments and nongovernmental organizations to institute appropriate interventions by way of public education and enlightenment, as well as case detection and early treatment to mitigate the devastating consequences of delayed or poorly managed cases.


  • Open Access

    A Mini-National Surveillance Study of Resistance Profiles of Staphylococcus Aureus isolated from Clinical Specimens across Hospitals in Nigeria

    by Nubwa Medugu, Philip I. Nwajiobi-Princewill, Shuwaram A. Shettima, Manga M. Mohammed, Yahaya Mohammed, Kennedy Wariso, Comfort N Akujobi, Oyinlola O Oduyebo, Kenneth C. Iregbu

    Background: Infections with Staphylococcus aureus cause significant morbidity and mortality worldwide. Resistant strains of S. aureus to commonly used antibiotics are being increasingly encountered in clinical practice, necessitating the need to determine the resistance pattern in Nigeria. Methods: Antibiotic susceptibility testing was performed on 360 S. aureus isolates from clinical specimen from seven hospitals across the six geo-political regions of Nigeria using Kirby Bauer disc diffusion technique, and E-test for vancomycin. Cefoxitin 30 μg disc was used to determine methicillin resistance, and D-test for inducible clindamycin resistance. Results: Methicillin-resistant S. aureus was confirmed in 176 (48.9%) of the isolates, 346 (96%) for penicillin G and 311 (86.4%) for trimethoprim. 175 (99.4%) of the 176 resistant to methicillin were susceptible to vancomycin. Linezolid, tigecycline, chloramphenicol and clindamycin had susceptibilities of 341 (94.7%), 332 (92.2%), 298 (82.8%) and 290 (80.6%) respectively. Inducible clindamycin resistance was elucidated in 25 (29.1%) of the 86 isolates. Generally, MRSA isolates were more resistant than methicillin-sensitive S. aureus (MSSA) to all antibiotics tested. Conclusion: Staphylococcus aureus rates of resistance are high and call for urgent action such as antibiotic stewardship programmes and periodic surveillance to enhance clinical outcomes. While targeted therapy is preferred, options for empiric treatment include chloramphenicol, clindamycin, linezolid or vancomycin.


  • Open Access

    Profiles of acute bacterial meningitis isolates in children in National Hospital, Abuja

    by Kenneth C Iregbu, N Abdullahi

    Background: Acute bacterial meningitis (ABM) is an important cause of morbidity and mortality throughout the world. It is an acute medical emergency that requires urgent rational antibiotic therapy, especially in neonates and young infants. Determining the pattern and susceptibility of isolates of ABM among children for prompt treatment of this important cause of mortality and morbidity is very important. This study determined the types and the antimicrobial susceptibility pattern of ABM isolates among children at the National Hospital, Abuja. Materials and Methods: This is a retrospective study carried out at the National Hospital Abuja (NHA), Nigeria. Laboratory data for a period of 3 years, January 2010-December 2013 were reviewed, and all bacterial isolates and their antibiotics sensitivity testing results for children aged 0-15 years, and other relevant information extracted and analyzed. Study center was the NHA. Results: Twenty-eight bacterial pathogens were isolated from a total of 542 cerebrospinal specimens over the study period, giving a yield of 5.2%. The four most common pathogens isolated were Staphylococcus aureus (32.2%), Klebsiella pneumoniae (21.5%), Streptococcus pneumoniae (17.6%), and Escherichia coli (14.3%). Whereas, 28.6% of all the infections occurred in neonates alone, children 2 years and below had 85.7% of all the infections, with male preponderance. Isolates of S. aureus and S. pneumonia tested were both 100% susceptible to amoxicillin-clavulanic acid and Cefuroxime; S. pneumoniae was equally sensitive to Ceftriaxone. K. pneumoniae was 100% sensitive to Imipenem, but 83% to ceftriaxone. 75% of the isolated E. coli strains were sensitive to ceftriaxone, amoxicillin-clavulanic acid, and amikacin, 100% sensitive to imipenem. Conclusion: Meningitis in children as seen in the National hospital is almost equally caused by both Gram-positive and Gram-negative organisms, predominantly by S. aureus, S. pneumoniae, K. pneumoniae, and E. coli. Available drugs remain active against these organisms.


  • Open Access

    The impact of a HIV prevention of mother to child transmission program in a nigerian early infant diagnosis centre

    by Iregbu Kenneth Chukwuemeka, Chukwuemeka Isa Fatima, Zubair Kabiru Kabiru, Olaitan Olukayode

    Background: Mothers infected with human immunodeficiency virus (HIV) can transmit the virus to their babies in utero, intrapartum or postpartum through breastfeeding. Maternal to child transmission can be prevented through administration of antiretroviral drugs to mother and child, and through restriction of breastfeeding. This study evaluated the effectiveness of prevention of mother-to-child transmission (PMTCT) activities in reducing the incidence of HIV infection among exposed babies at the National Hospital Abuja, Nigeria. Materials and Methods: Early infant diagnosis laboratory records of 515 exposed babies aged below 18 months who had polymerase chain reaction (PCR) test between January 1 st 2011 and December 31 st 2012 were reviewed. The details of antiretroviral (ARV) therapy commencement for mother and baby, infant feeding choices, mode of delivery and HIV test results were analysed. Results: Of the 515 samples tested, 36 (7.0%) were found to be positive. The mean age of exposed children tested was 4 months. Highest prevalence was among children in the age group 6-18 months (16.1%). There was statistically significant association between HIV positive results and age. (P = 0.0000). If the mother and child pairs received ARVs, the prevalence was 1.3%, whereas if the mother only received ARV, then the prevalence was 4.6%, and when only the child received ARV the prevalence was 20.0%. When neither the mother nor the child received ARVs, the prevalence was 66.7%. Conclusion: There was a high prevalence of HIV among exposed children in our setting, especially if the mother and child pairs did not receive any form of antiretroviral prophylaxis. This further emphasises the usefulness of ARVs as the single most important intervention in PMTCT. Therefore, there is need to expand antiretroviral coverage, ensure access of the PMTCT program, and provide effective services to support infected children.


  • Open Access

    Quality assurance in blood culture: A retrospective study of blood culture contamination rate in a tertiary hospital in Nigeria

    by Iregbu Iregbu Chukwuemeka, Yakubu Samuel

    Background: Blood culture is a critical tool for diagnosing septicaemia. Quite frequently, contamination of blood sample poses a great challenge to accurate diagnosis. This study evaluated the rate of blood culture contamination in our hospital over a one-year period. Materials and Methods: It was a retrospective study of 1032 blood cultures carried out in a clinical laboratory of a tertiary hospital in North Central part of Nigeria between 2010 and 2011. Results: There were 730 blood cultures from paediatric and 302 adult patients. The overall yield was 22%; 107 out of the 730 were contaminated giving a contamination rate of 10.4%. Contamination rate was higher in children than in adult (11% vs 8%) specimen. These rates were much higher than the acceptable benchmark of 2-3%. The main contaminants were coagulase negative Staphylococcus, Bacillus species, Diphtheroids and Enterococcus species. Conclusion: Contamination rate is high, and mainly due to normal skin flora, suggesting aseptic collection challenges as the main cause. We recommend a review of the entire process of blood collection for culture and analysis with a view to instituting appropriate quality assurance measures to reduce the contamination rate.


  • Dual Path Platform HIV 1/2 assay: evaluation of a novel rapid test using oral fluids for HIV screening at the National Hospital in Abuja, Nigeria

    by Kenneth C. Iregbu, Javan Esfandiari, Joseph Nnorom, Samuel A. Sonibare, Stella N. Uwaezuoke, Stella O. Eze, Nasiru Abdullahi, Akeem O. Lawal, Babatunde S. Durogbola


    • 1 September 2007
      • Vol. 36  (3) , 225-8

    Extended spectrum Beta-Lactamase-producing Klebsiella pneumoniae septicaemia outbreak in the Neonatal Intensive Care Unit of a tertiary hospital in Nigeria.

    by K C Iregbu, U Anwaal

    Between March and August 2002 a cluster of nosocomial septicaemia associated with Extended Spectrum beta lactamase (ESBL)-producing Klebsiella pneumoniae was observed in 11 neonates from the neonatal intensive care unit of a 200-bed tertiary hospital in Abuja, the Federal Capital territory of Nigeria. An investigation was conducted to identify the possible reservoirs and mode of transmission. Infection control measures and epidemiologic surveillance were executed. The environment was investigated by collecting and processing several swab samples for microbiological studies. Antibiogram tests and extended spectrum beta lactamase production test were performed on all K. pneumoniae isolates from both the environment and the patients, and all bacteraemic and environmental isolates of K. pneumoniae compared. A total of 30 K. pneumoniae isolates made up of 17 from the patients and 13 from the environment were analysed. An identical antibiogram was found in 24 isolates, which included all the 17 from the patients and the 7 from the hands of staff, sink and incubator surface in the NICU. Mortality rate from the outbreak was 36.4% and constituted 10.8% of all deaths in the unit in 2002. Overall mortality in the unit for 2002 was 28.9%. The outbreak significantly caused more deaths than usual in the unit. The nosocomial septicaemia was caused by a single ESBL-producing strain of K. pneumnoniae brought into the hospital by a neonate delivered and admitted from an external health institution. Sink and the incubator were also contaminated by the same strain.


  • Prevalence of Kaposi's Sarcoma Among Adult HIV-Seropositive Patients Seen in a Designated HIV Treatment and Care Center in Abuja, Nigeria

    by K. C. Iregbu, O. Y. Elegba

    Background: There is a dearth of information on the prevalence of AIDS-associated Kaposi's sarcoma (AAKS) in Nigeria despite the HIV National seroprevalence of 5% and the occurrence of the disease in people living with HIV/AIDS. Objective: To determine the prevalence of AAKS among HIV-seropositive adults seen in an HIV/AIDS treatment and care center in Abuja, Nigeria. Design: This was a retrospective study of all cases seen over a period of 42 months. Method: Medical records of the 1591 patients comprising 857 males and 734 females were reviewed, and relevant data such as age, sex, CD4 count at diagnosis of AAKS were obtained and analyzed.Results: A prevalence of 0.8% was found, with a male:female ratio of 2:1. Females presented at earlier ages and relatively lower CD4 count than did males. Conclusion: Easy access to antiretroviral medications and a well-targeted education and awareness campaign will help reduce the incidence and prevalence of the disease. The inability to perform histologic examinations on all suspected cases calls for a well-designed prospective study to determine the actual prevalence of Kaposi's sarcoma in HIV-seropositive patients in Nigeria.